期刊文献+

北京地区26家医院2011-2013年妇产科铂类抗肿瘤药使用情况分析与比较 被引量:7

Analysis of the Usage of Platinum Anticancer Drugs in Obstetrics and Gynecology Departments of 26 Hospitals in Beijing form 2011 to 2013
下载PDF
导出
摘要 目的:研究北京地区26家医院2011-2013年妇产科铂类抗肿瘤药使用情况。方法:对参与《医院处方分析》课题组研究的2011~2013年妇产科铂类抗肿瘤药使用情况进行统计,并计算DDDs、DDC。结果:北京26家医院2011至2013年妇产科铂类抗肿瘤药数量、金额、DDDs、DDC统计分别见征文。结论:妇产科铂类抗肿瘤药DDDs排序为顺铂、卡铂、奥沙利铂。DDC排序是奥沙利铂、卡铂、顺铂。 Objective: To investigate the usage of platinum anticancer drugs in obstetrics and gynecology departments of 26 hospitals in Beijingform 2011 to 2013. Methods: Statistics of the usage of platinum anticancer drugs in 26 hospitals of Beijing form 2011 to 2013 were collected and analyzed. DDDs and DDC were calculated. Results: Quantities,amounts, DDDs, and DDC of platinum anticancer drugs used in the 26 hospitals were calculated.Conclusion: Platinum drugs with the highest DDDs werecisplatin, carboplatinand oxaliplatin and withthe highest DDC wereoxaliplatin, carboplatin, and cisplatin.
出处 《药品评价》 CAS 2014年第16期24-24,26,27,共3页 Drug Evaluation
关键词 妇产科 铂类抗肿瘤药 DDDS DDC Obstetrics and Gynecology Platinum Anticancer Drugs DDDs DDC
  • 相关文献

参考文献6

二级参考文献28

  • 1张继春,金岩,李大魁,彭名炜.北京地区主要抗生素使用频度分析[J].中国药学杂志,1994,29(6):373-376. 被引量:34
  • 2刘屏,张志萍,陈宜鸿,孙映和,颜青,李辉.我院门诊处方中抗菌药物使用研究[J].中国药房,1995,6(2):23-24. 被引量:15
  • 3刘红岩,付招娣,韩锐.三尖杉酯碱和高三尖杉酯碱对肿瘤细胞Ⅳ型胶原酶的分泌及活性的影响[J].中国药理通讯,2005,22(3):28-28. 被引量:1
  • 4Zhang J, Liu D, Li Y, et al. Status of non-classical mononuclear platinum anticancer drug development. Mini Rev Med Chem, 2009, 9 (11) : 1356-1366.
  • 5Alami NZ, Li ZH, Engel JG, et al. Comparative preclinical anti-pro- liferative activity of lobaplatin vs cisplatin, carboplatin, oxaliplatin and satraplatin in breast and ovarian cancers. Proceeding of the 98th AACR Annual Meeting, Los Angeles: CA, 2007: a4780.
  • 6Xie CY, Xu YP, Jin W, et al. Antitnmor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung canc- er. Anticancer Drugs, 2012, 23(7): 698-705.
  • 7Dai HY, Liu L, Qin SK, et al. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro. Biomed Pharmacother, 2011, 65(3) : 137-141.
  • 8Luo J, Guo RP, Lai EC, et al. Transarterial chemoembolization for unreseetable hepatocellular carcinoma with portal vein tumor thrombo- sis: a prospective comparative study. Ann Surg Oncol, 2011, 18 (2) : 413-420.
  • 9Engel JB, Martens T, Hahne JC, et al. Effects of lobaplatin as a sin- gle agent and in combination with TRAIL on the growth of triple-nega- tive p53-mutated breast cancers in vitro. Anticancer Drugs, 2012, 23 (4) : 426-436.
  • 10Kirpensteijn J, Teske E, Kik M, et al. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase Ⅱ evaluation. Anticancer Res, 2002, 22(5): 2765-2770.

共引文献1942

同被引文献75

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部